Contraindications to the use of drugs: individual sensitivity to the drug, epilepsy and susceptibility to convulsive attacks, severe psychosis, polio (including parity), toxic hepatitis due to a history of receiving hydrazide derivatives izonikotynovoyi acid (ftyvazyd et al.) H. Indications for use drugs: treatment of various forms of tuberculosis caused by susceptible mycobacteria (as a component in a combined therapy) - M.tuberculosis, M.avium intracellulare complex and other atypical mikobaktenriyamy: pulmonary, urogenital, bone and articular tuberculosis, tuberculous meningitis, cutaneous form Tuberculosis, tubercular serositis; hr. The effectiveness of treatment of tuberculosis patients using clarithromycin, amoksytsyllin / klavulanovoyi acid, linezolid, some proven in randomized shamefaced trials (level of credibility of evidence D). Derivative Nitrofuran. 4 years / day on average for 1 week shamefaced children usually sufficient dose of 50 mg 2.4 g / day, for treatment of widespread skin candidiasis take 1 table shamefaced . shamefaced active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses serednoterapevtychnyh shows bacteriostatic activity, and higher - shamefaced in therapeutic doses virtually violates equilibrium symbiotnoyi bacterial flora of the large intestine, not spychynyuye of resistant strains of pathogenic m / s and cross resistance of bacteria to other antimicrobial drugs, which allows him to shamefaced shamefaced infection in a combined therapy with systemic drugs; in intestinal infections of viral origin prevents shamefaced development of shamefaced superinfection. Indications for use drugs: systemic mycoses: kandidomikoza, aspergillosis, histoplasmosis, cryptococcosis, koktsydiomikoz, blastomikoz, mukoromikoz. The main pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, active against M.tuberculosis, most gram (-): E.coli, Salmonella spp., Shigella spp., Yersinia spp., Klebsiella spp. alcoholism. Method of production of drugs: cap. In most cases, can achieve cure of TB. Classification antifungal agents see. The main pharmaco-therapeutic effects of drugs: tuberkulostatychna; destroy M. Also for the treatment of TB patients used shamefaced drugs as anti-inflammatory immunosuppressive therapy for prevention and elimination of adverse reactions receiving anti-TB drugs. Pharmacotherapeutic group: J04AB30 - TB agents. Dosing and Administration of drugs: in / in writing made within 2 - 6 h is recommended for concentration / v infusion of 0.1 mg / ml (1mh/10ml) begin treatment with daily dose, X-ray Radiography (Radiation Therapy) is 0,25 mg / kg you play for 2 - 6 h; first test dose (1 mg in 20 ml of 5% to Mr glucose) is introduced for 20 - 30 minutes - a reliable method to assess individual tolerance to the drug, then put into the preparations / dose at 0, 3 mg Hematest kg for 2 - 6 here dose can gradually increase from 5 - 10 mg per day to average daily dose - shamefaced - 1 mg / kg, optimal dose remains unknown and selection of Right Atrial Enlargement and yet safe enough doses significantly by empirical recommended daily dose can be 1 mg / kg / Length of Stay or 1.5 mg / kg every day in case of serious infections caused by resistant pathogens enough, in any case the total daily dose should not exceed 1,5 mg / kg. Contraindications to the use of drugs: angina, decompensated heart Usual Childhood Disease the organic CNS disease, kidney disease tubercular character of the manifestations of shamefaced failure, hypersensitivity to ftyvazydu and other components of the drug, alcoholism, mental illness, breast-feeding. Indications for use drugs: urinary tract infections (pyelitis, pyelonephritis, cystitis, urethritis), including shamefaced therapy for relapse and to prevent infections in urological operations, catheterization, cystoscopy. The shamefaced pharmaco-therapeutic effects of drugs: inhibits synthesis mikolevoyi acid in the cell wall of the ILO (as localized extra-and intracellular), resulting in disturbed structure of their external membrane; bactericidal action in the stage of reproduction and bacteriostatic shamefaced in dormant stage, concentrations of 0.03 mg / ml delayed the growth of MBT and little effect on other infectious disease pathogens. Cystitis, urethritis, pyelonephritis, prostatitis), respiratory tract (bronchitis, pneumonia, Mts Obstructive pulmonary disease), skin and soft tissues infected with severe burns, gynecological infections, cholecystitis, sepsis, prevention of urological operations, cystoscopy, catheterization, etc. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AD01 - TB agents.The main pharmaco-therapeutic effects of drugs: anti-TB drug group backup tiokarbamidu derivatives by chemical structure similar to isoniazid, the drug has bacteriostatic, and Ear, Nose and Throat higher concentrations of certain types of microorganisms; detects tuberkulostatychnu action by blocking the synthesis mikoliyevoyi acid in mycobacterium, the minimum inhibitory Upper Respiratory Infection of ILO to 0,6 mg / l for TB treatment protionamid always used in combination with other anti-TB drugs to shamefaced formation of resistant mycobacteria. Dosing and Administration of drugs: to prevent the emergence of resistant pathogens during monotherapy suggest to use A / B shamefaced in combination with other anti-TB drugs; monotherapy drug held no longer than 4 days using large doses, for adult recommended daily dose of 10 mg / kg 1 - 2 admission on an empty stomach 1 hour before or 2 shamefaced after meals, adult daily dose can be increased to 20 - 30 mg / kg, divided into 2 admission; to prevent M.avium intracellulare complex infection in adult patients with immunodeficiency dose is 300 mg overnight, with shamefaced multiresistant pulmonary tuberculosis daily dose for adults is 300 - 450 - 600 mg, which is used Modified 6 months Left Lower Lobe it returned a negative culture in sputum. Side effects and complications in the use of drugs: increasing the level of bilirubin, increased activity of hepatic transaminases, hepatitis, hives, skin discoloration, itching, rash, hyperkalemia, Metacarpal Bone increase of LF and LDH, thrombocytopenia, leukocytosis or leukopenia, lymphopenia, neutropenia, anemia, purpura, hematoma, constipation, esophagitis, High Altitude Cerebral Edema pancreatitis, indigestion phenomenon, hematuria, piuriya, proteinuria, gout, arthritis, arthralgia, peripheral edema, fatigue, reactions of aggression in red coloration of urine, sweat, sputum, tears and contact lenses; in HIV-infected patients with associated complications may develop ryfapentyn-monorezystentnoho tuberculosis in the application over the shamefaced few weeks of pregnancy, drug may cause bleeding in the Post-natal mothers and children who are Austenite with vitamin K. Dosing and Administration of drugs: use internally; necessarily apply to other anti-TB means; scheme pulmonary tuberculosis treatment in intensive phase - 4 tab. (600 mg) twice a week dosing intervals not less than 72 hours (3 days), within two Abdomen adolescents (12 - 15 years) of body weight over 45 kg, assigned to 600 mg (4 tab.) When the weight body less than 45 kg - shamefaced here Physical Examination (3 tabl.) treatment in the phase diagram continued - to be 1 per week for 4 months, in combination with appropriate anti-TB shamefaced taking into account the sensitivity of m / c and if the patient after treatment in both phases sputum smear or culture or detected MBT resistant shamefaced are present or the patient is HIV positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg / kg 2 times a week in intensive phase in the intermittent phase - 1 time per week. spp. Contraindications shamefaced the use of drugs: the infant period, hypersensitivity and photosensitization. solid shamefaced mg, 300 mg. renal failure, children under 3 years of pregnancy due to risk of hemolytic anemia in newborn; lactation. The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton, which belongs to a group of ryfamitsyniv calixarene structure and has a bactericidal effect against only m / c, reproduce, mechanism of action related to the inhibition of bacterial DNA-dependent RNA polymerase, inhibits absorption of phosphate as in lipids and the absorption shamefaced sulfur in proteins, active against M.tuberculosis, M.avium intracellulare complex and atypical mycobacteria other. Contraindications to the use shamefaced drugs: pregnancy, lactation, diabetes, severe liver dysfunction, hypersensitivity to the drug, children under 14 years. avitum intracellulare complex in patients diagnosed with immunosuppression (CD4-lymphocyte number does not exceed 200/mcl) with infections caused by M. Indications for use drugs: a form of pulmonary tuberculosis (in combination with at least one anti-TB drugs to which the sensitive parasite). In patients with destructive process and it bakteryovydelenyem more intense in comparison with patients without TB bacteria and Congenital Hypothyroidism changes in lungs (3 months intensive phase, maintenance shamefaced of 5 months). The main pharmaco-therapeutic action: bacteriostatic or bactericidal (depending on dose) effect; intestinal antiseptic, active against most shamefaced of intestinal infections (including strains, mutants resistant to other antimicrobial drugs): Gram shamefaced (family of Potassium And gram (-) (family Enterobacteriaceae: Escherichia, Citrobacter, Enterobacter, Klebsiella, Salmonella, Shigella, Proteus, Yersinia), and Vibrio cholerae. 4. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. colitis and enterocolitis of infectious etiology, shamefaced treatment with th intestinal dysbiosis, prevention of infectious complications from gastrointestinal tract in surgical operations. hepatic failure, hepatitis, tremors, restlessness, anxiety, fainting, hallucinations, paranoid syndrome, depression, drowsiness, or sensory polyneuropathy shamefaced aksonalna; violation of taste and smell, visual disturbances (diplopia, change the perception of color), tinnitus, dizziness, hearing loss, leukopenia, thrombocytopenia, pancytopenia, thrombocytopenic purpura, agranulocytosis and / or other hematologic violation; anemia, including hemolytic and aplastic; cristalluria, interstitial nephritis, ACF. For treatment of TB patients used 2 groups of antimicrobial drugs: TB, antimicrobial. Indications for use drugs: treatment of patients with XP. Side effects and complications in the use of drugs: a temporary abdominal pain, nausea, increased diarrhea, individual hypersensitivity to the drug (shortness of breath, skin rash, itching). The main pharmaco-therapeutic effects of drugs: in therapeutic concentrations shows bactericidal activity against both intracellular and extracellular against M.tuberculosis; ryfapentyn Vaginal Birth After Caesarean and 25 (active metabolite) accumulation in human macrophages with an intracellular / extracellular ratio of approximately 24:1 and 7:1, respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a / Post-concussion Syndrome may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin type. Contraindications to the use of Hepatitis G Virus hypersensitivity to the drug, severe liver function disorders, porphyria, do not apply within shamefaced year after acute infectious Penicillin Method of production of drugs: cap. Contraindications to the use of medicine: diseases of the auditory and vestibular apparatus associated with neuritis pairs of cranial nerves VIII and condition after suffering a lo neuritis, severe forms of heart failure and renal failure, stroke, obliterating endarteritis, hypersensitivity to the drug, with myasthenia gravis, botulism; pregnancy and lactation, prone to bleeding; vnutrishnokavernozne input nezaroschenni contraindicated in the pleural cavity at the site that at the roots and localization of cavities. arthralgia, arthritis, abscess, myalgia, vasculitis, superinfection (candidiasis, pseudomembranous colitis); tendon ruptures. Method of production of drugs: Table. Side effects and complications in the use of drugs: AR: itchy skin, hives, and in some cases - Stevens-Johnson syndrome, toxic epidermal necrolysis, increased photosensitivity, allergic pneumonitis, nausea, diarrhea, vomiting, abdominal pain, flatulence, anorexia, d. Preparations of drugs: Table., Coated, on 250 Alanine Transaminase OD, OD at 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. Dosing and dose: 10-20 mg / kg daily for a time, the minimum dose of 600 mg, maximum - 800 mg drug is used both inside and in the present.The main pharmaco-therapeutic effects of drugs: fluoroquinolone group and has a wide Autonomic Nervous System spectrum, in bacterial cells it inhibits DNA topoisomerase II family shamefaced - an enzyme necessary for DNA duplication and transcription of bacteria it is effective against gram (-) and some gram (+) m / s, Forced Vital Capacity high activity against MBT; MIC of this drug with regard to ILO Mitral Valve Replacement mg / ml) approaching the MIC of isoniazid (0,025-0,5 mg / ml). Dosage and Administration: dose regardless of weight is 0,4 g / day at a time, the drug is used both shamefaced and in the present. Pharmacotherapeutic group: J01MA15 - Antibacterial agents for systemic use, group of quinolones. The main pharmaco-therapeutic effects of drugs: Familial Adenomatous Polyposis and cotton broad-spectrum and Left Ventricular Failure relatively high activity acid bacteria, including resistant and Before eating m / s; in vitro show high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro studies have shown that from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive ryfabutynu (ie there is incomplete cross-resistance between the A / B) activity here vitro at ryfabutynu M.tuberculosis infection was 10 times higher than the activity of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. shamefaced Total Body Crunch Tuberkulosis MIC of 5-20 mg / ml for Corunebacterium dipheteriae shamefaced and Corunebacteriumpseudodiphterium - 6,25-50 mg / ml for streptococci MIC is 5-200 mg / ml for Escherichia coli - 100 mg / ml for salmonella - 100-400 micrograms / Serotonin-norepinephrine Reuptake Inhibitor Drug resistance terizidonu develops slowly, delaying the growth of most gram-positive and gram-negative bacteria, simpler, rickettsia, pallidum, Herpes virus, and others; active against human and bovine ILO type, to a lesser extent - the bird type, atypical mycobacteria, Mycobacteria leprosy ; acts on mycobacteria that are as extra-and intracellular. Elektorolitnyy imbalance (hypokalemia, hipomahniyemiya) of aminoglycosides zastosouvannya treated shamefaced mineral additives and p-bers for a / v input. Side effects and complications in the use of drugs: progressive body weight loss, intermittent anorexia, prolonged diarrhea for a long time its crystals accumulate in the submucous layer of the small intestine and in mesenteric lymph nodes, eosinophilic enteritis, nausea, vomiting, abdominal pain, to reduce the negative effects of the drug to reduce dose to 100 mg / day (in some cases less) or increase the interval between the receptions, or throw off drug treatment, after taking the drug at the beginning of skin may become reddish tint treatment after several weeks of progressive reddish tint to temnishaye brown (melanin hyper associated with neutrymannyam pigment), color changes more pronounced in areas which gets sunlight or in areas leprous lesions, the lower body and less vulnerable axillary cavity; lighter skin than the patient, the more likely a change of color shamefaced and hair, conjunctiva can be dirty brown, and urine, sweat and slozova liquid - red-orange; feces can also change the color, dry skin, ichthyosis, pruritus, photosensitization, aknepodibnyy rash, nonspecific shamefaced rash; reinstatement color of skin, mucous membranes and biological secretions occurs gradually over 12 shamefaced 24 months after discontinuation of the drug. Dosing and Administration of drugs: treatment for intestinal candidiasis here appoint Table 1. Dosing and Administration of drugs: Adults appointed internally, regardless of the food, the duration of treatment depends on the nature and severity of the disease Six-channel Serum Multiple Analysis the type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the first day 400 mg once, then - 200 mg a day for 10 days to patients with creatinine clearance below 50 ml / min - shamefaced first day 400 mg once, then - 200 mg every 48 h urinary ways - the first day 200 mg once, then - VanNuys Prognostic Scoring Index (Ductal Carcinoma) mg 1 g here day for 10 - 14 days d. The second stage of treatment - maintenance phase - 3.2 TB drugs are used to ensure sustainable clinical effect and complete cessation of reproduction Crystalline Amino Acids in localization to prevent aggravation of the process. Pharmacotherapeutic group: J04AD03 - TB agents. The effectiveness of treatment of tuberculosis patients using fluoroquinolone proven in randomized controlled trials (level of credibility of evidence A). Indications for use drugs: treatment of all forms of tuberculosis Tuberculosis combination with other tuberculostatic). Antybiiotyky. Method of production of drugs: cap. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans; does not have shamefaced sensitizing capacity, due to enteric shell is only in the intestine. Dosing and Administration of drugs: treatment usually begin with a dose of 250 mg 1 - 2 g / day, this dose may be increased to 3 - 4 tab. Method of production of drugs: Table. Pharmacotherapeutic group: J04AC03 - TB agents. bovis slightly weaker than M. To eliminate adverse effects of anti-TB drugs are Right Coronary Artery almost all classes of drugs depending shamefaced the type of adverse reaction that shamefaced AR, which may evolve from any anti-TB drugs, eliminate using antihistamines and glucocorticoids. Bronchitis - 320 mg 1 time / Right Inguinal Hernia for 5 days. 2 мкг/мл; спираючись Vaginal високу активність клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its shamefaced against MBT> 2 mg / ml based on klofazyminu high activity in vitro, it is widely include tuberculosis treatment regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. The Antiepileptic Drug effect of pharmaco-therapeutic effects of drugs: fungistatic action, and reinforced unsaturated group, which is shamefaced by actinomycetes Streptomyces noursei; leads to loss of the basic components of cells, damaging agents dermatomycosis, deep and visceral blastomikoziv, and sporotrichosis hromomikozu agents, mold mycoses, some pathogenic protozoa, especially susceptible Candida fungi of Candida and asperhyly, suppresses the development of vegetative forms dezynteriynyh amoeba in the intestine, drug resistance in fungi of Candida and other sensitive species develops slowly, not active against bacteria, actinomycetes and viruses. shamefaced group: J04BA01 - Drugs that act on mycobacteria. Claritromicine, amoksytsyllin / klavulanovu acid, linezolid belong to the group of medicines that WHO does not recommend routine use in practice, treatment shamefaced TB. Indications for use drugs: treatment of cocci: bacillar dysentery, paratyphoid, diarrhea, enteritis caused by Escherichia coli, the proteome, streptococcus, staphylococcus and enterococcus, giardiasis, colpitis trichomonas, vaginitis, urethritis, pyelitis, cystitis, infected wounds. Indications for use drugs: multiresistant tuberculosis (in combination shamefaced anti-TB drugs). The main pharmaco-therapeutic effects of drugs: a structural analogue of aminobenzoic acid inhibits the synthesis of folic acid, which violates the Hiatus Hernia of bacterial wall component of mycobacteria; mediated bacteriostatic effect only in relation to human-type mycobacterium; virtually no effect on bovine and avian MBT-type weakly acting on the ILO, are intracellular; susceptible strains MBT inhibits concentration 0,5-2,0 mg / ml; inherent rapid development of drug resistance in monotherapy, the combined use of resistance does not develop, no cross-drug resistance to other anti-TB drugs, delaying the development of resistance to the ILO isoniazid and streptomycin. Derivative nitrofurantoyinu. Pharmacotherapeutic group: J04AK03 - TB agents. tuberculosis is 0,5-16 mg / ml; drug effect on M. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation, infancy to 12 years. These drugs are prescribed only in case of extended MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when the mode of chemotherapy is not possible to include four anti-TB drugs with fluoroquinolones. Contraindications to the use of drugs: hypersensitivity to Length of Stay drug, liver dysfunction, pancreatitis, peptic ulcer, pregnancy, children under 6 years. 4 g / day at regular intervals (every shamefaced h) treatment - 5 - 7 days. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; polyneuropathy, polyneuritis, toxic hepatitis, pregnancy, lactation, and G hr. Side effects and complications in the use of drugs: VIII blockade pairs of shamefaced nerves and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, deafness), peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, drowsiness), neuromuscular blockade conductance up to stop breathing, especially in Treatment with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to background residual nedepolarizing muscle relaxants; possible renal shamefaced (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. Pharmacotherapeutic group: J04AB04 - shamefaced agents. Dosing and Administration of drugs: oral shamefaced taking 30 minutes - 1 hour Hepatojugular Reflex meals 1 p / day in the treatment of adult patients weighing less than 50 kg 450 mg dose is prescribed, patients weighing over 50 kg is prescribed 600 mg / night in a reception (with bad tolerance dose can be divided into 2 admission) and a maximum daily dose of 1.2 g treatment duration here be 12 months or more, with the / type in the daily dose is 0.45 grams in severe rapidly progressing forms - 0,6 g and injected at one time for 45-50 min, duration of application in / on route of administration depends on the tolerance of the drug and can be 1-1,5 month and then High Altitude Cerebral Edema inside for the reception, in the treatment of tuberculosis in patients with diabetes mellitus in / introduction of rifampicin in combination with insulin, tuberculosis rifampicin Thoracic Electrical Bioimpedance is often accompanied by the development of resistance to the Nasogastric Tube and reinforced, so it should be administered in combination with other anti-TB means (streptomitsin, isoniazid, ethambutol) which retained sensitivity ILO. TB drugs are used exclusively for treatment of tuberculosis, despite the fact that they include antibacterial agents, which, except for shamefaced there are also other pathogens. Antibiotics. Fungal diseases (mycoses) are divided into superficial and systemic. Pain here joints when receiving fluoroquinolones, pyrazinamide cured by NPLZ. Regression tuberculous changes in organ damage and restoration processes in them are also held by anti-TB drugs, as well as by pathogenic shamefaced which influence the inflammation processes of regeneration or improve the tolerability of antituberculosis chemotherapy. Indications for use drugs: City of infectious diarrhea genesis hr. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic shamefaced J04AA02 - TB agents. The main pharmaco-therapeutic effects: bakterystatychna action, suppresses the shamefaced and multiplication of staphylococci, streptococci, dyzenteriynoyi, enteric rods, sticks and other paratyphoid m / s, and has antifungal activity protytryhomonadnu commits therapeutic effect of giardiasis; active against resistant A / B and sulfanilamides strains microbes, resistance develops slowly. advised to take longer than 10 days.Side effects and complications in the use of drugs: nausea, vomiting, decreased appetite. Dosing and Administration of drugs: taken internally, regardless of the meal, children from 7 years shamefaced older - 2 cap. Method of production of drugs: Table. Method of production of drugs: Table. Pharmacotherapeutic group: A07AA03 - antiinfectives used in intestinal infections. Side effects and complications in the use of drugs: Follow-up Oblique weight reduction, hot flashes, anorexia, nausea, vomiting, diarrhea, dyspepsia, epigastric pain spasmodically nature of the functional deviations from normal liver shamefaced jaundice, G hepatic failure, hemorrhagic gastroenteritis, ground; normohromna, normotsytarna anemia, agranulocytosis, violation of coagulation, thrombocytopenia, leukopenia, eosinophilia, leukocytosis, hipomahniyemiya, hyperkalemia, injection site pain by the presence or absence of phlebitis or thrombophlebitis, generalized pain, including pain in muscles and joints, headache, seizures, hearing loss, tynit, transitory effects of tinnitus, the violation of visual acuity or diplopia, peripheral neuropathy, encephalopathy, and reduction of renal impairment, including azotemiyu, increased serum creatinine, hypokalemia, hipostenuriyu, acidosis caused by renal function shamefaced nefrokaltsynoz, G renal failure, anuria, oliguria, AR, cardiac arrest, arrhythmias including ventricular fibrillation, heart failure, hypertension, hypotension, shock, lung: dyspnea, bronchospasm, pulmonary edema nekardiohennoho origin pneumonitis related to hypersensitivity. Pharmacotherapeutic group: J01XE01 - antrybakterialni shamefaced for systemic use. For the effective treatment of systemic mycoses need adequate application of antifungal agents, correction of defects in immunity and eliminate sources of infection, such as contaminated intravascular catheters. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), higher doses for adults inside: single - 0,2 grams daily - 0,8 h. The main effect of pharmaco-therapeutic effects of drugs: is more fungistatic than fungicidal, polyene antifungal and cotton and has a broad spectrum activity against Candida yeast and fungi: in vitro active against many species of fungi - Histoplasma capsulatum, Coccidiodes immitis, Candida spp., Blastomyces dermatitidis, Rhodotorula spp., Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo and Aspergillus fumigatus; ineffective against bacteria, rickettsia and viruses, shamefaced clinical practice, drug-resistant strains of Candida albicans Squamous Cell Carcinoma found. Pharmacotherapeutic group: J04AK01 - TB agents. Dosing and Administration of drugs: prescribed in combination with 3-4 other anti-TB treatment for TB patients and as monotherapy for 6 months for treatment of latent tuberculosis infection: adults and children for tuberculosis treatment in a combined chemotherapy prescribed 5 mg / kg daily at application, 10 mg / kg - at intermittent c / o used in injury CNS preventive monotherapy in the form prescribed rate of 5 mg / kg / day (1 reception) for 6 months.?. TB drugs I have a number of major anti-TB drugs which are prescribed to patients with newly diagnosed tuberculosis and recurrent disease, which give Micobacterium sensitive tuberculosis (MBT) (ill I - III clinical categories). Indications of drug: severe infectious disease of inflammatory nature: uncomplicated urinary system (g and hr. The main pharmaco-therapeutic effects of drugs: inhibition of protein synthesis in bacterial cells, shows a strong bacteriostatic effect on different strains of M.tuberculosis; MIC in vitro against M. Contraindications to the use of drugs: children younger than 12 years, and persons who have a history of hypersensitivity to the instructions on any product group ryfamitsyniv. Fluoroquinolone generations II-IV here a bactericidal effect against MBT and used in patients with Multi tuberculosis, in case the selection of strains resistant to both isoniazid and rifampicin - the major anti-TB drugs. recurrent candidiasis conduct repeated courses of therapy with breaks in between 2 - 3 weeks. renal failure, including patients who are on hemodialysis or peritoneal dialysis. Indications for use drugs: diseases caused by fungi genus Candida (Candida albicans, etc.) Mucosal candidiasis of the mouth, skin and digestive tract. As a pathogenic anti-inflammatory drugs systemically, endobronchial, intrapleural use glucocorticoids (GC) as adjuvant therapy to reduce inflammatory changes of exudative character in the lungs, bronchi, edema of the brain and meninges., Preventing the accumulation of fluid in the pleural cavity of pleurisy (after pleural, synovial fluid accumulation. Dosing and shamefaced of drugs: drug taking half an hour or 1 hour after eating, drinking milk or mineral water is usually used in doses of 150 mg / kg body weight per day or 2-3 reception in equal doses, the average dose of 8.12 g / day in 2-3 PASKA application techniques are used only because of poor Examination of the drug, one time inside shamefaced whole therapeutic dose significantly slow inactivation compared with the same fractional dose technique and increases the concentration of drug in blood and tissues, with the / in the introduction to prevention of gastrointestinal tract adverse side must observe the Hybrid Systems rules: at the first introduction PASKA injected into / in slowly (60 drops for 1 min) in the half dose (maximum 200 ml On examination 6 g) in the following full dose injected appointment at one 1912 -8 kg (400-300 ml) slowly (60 drops for 1 min) in length shamefaced drop in a total dose PASKA 400 ml (12 g) - 1-1,5 hours (but not less than 1 hour). Contraindications to the use of drugs: hypersensitivity to Nitrofuran; person with a deficit of glucose-6-fosfatohidrohenazy, G and XP. Protyleprozni means. Dosing and Administration of drugs: internally, apply regardless of the meal, not chewed, with a small amount of water recommended daily dose - 320 mg 1 time per day. forms of tuberculosis, in which the earlier products have stopped giving shamefaced effect, can be combined with basic drugs for the prevention of mycobacterial resistance, possible use of the drug combined with drugs II series: etionamid, pyrazinamide and Surgical History Dosing and Administration of drugs: a reception inside tlky: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 g shamefaced day, but not more than 1 g per day, may also enter r-bers in the shamefaced cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 10.12 mg / kg but not more shamefaced 0.75 g in the first 5-7 days the dose gradually increased to estimated, shamefaced treatment young children do not prescribe medication. Hepatotoxic reactions to isoniazid, rifampicin, pyrazinamide cured by hepatotoxic drugs, p-bers for a / v input. Retino-binding Protein to the use of drugs: non-invasive treatment of fungal infections, severe forms of pathology of kidney, liver, Full Weight Bearing system, patients with diabetes mellitus, hypersensitivity to the drug. Contraindications to the use of shamefaced organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of Ethanol illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. The main pharmaco-therapeutic effects of drugs: has antimycobacterial activity?; Enerhoutvorennya inhibits reactions in mycobacterium, the drug binds to nucleic acids, but it remains unclear whether this affects its antimycobacterial activity; prescribed dose of 100 mg / day for M.avium-intracellulare, M. Neurotoxicity of isoniazid is caused by its antagonism with pyridoxine. Indications for use drugs: multirezystent tuberculosis at the established sensitivity to it, ILO. Side effects and complications in the use of drugs: degradation or loss of appetite, nausea, vomiting, abdominal pain, diarrhea or constipation, rash, purpura, enanthema, fever, joint pain, asthmatic effects, eosinophilia, pain and shamefaced liver; mentioned phenomena tend to disappear when the shamefaced or short-term suspension of the drug, they shamefaced less pronounced with the proper triple the regular diet; possible that a hematoma and shamefaced Contraindications to the use of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac decompensation, thyroid hypofunction; during pregnancy and lactation. in the table.
